PODD * logo

Insulet CorporationBMV:PODD * Stock Report

Market Cap Mex$428.6b
Share Price
Mex$6.04k
n/a
1Y9.4%
7D0%
Portfolio Value
​
View

Insulet Corporation

BMV:PODD * Stock Report

Market Cap: Mex$428.6b

Insulet (PODD *) Stock Overview

Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. More details

PODD * fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 26.52% per year

Risk Analysis

Shares are highly illiquid

Significant insider selling over the past 3 months

Large one-off items impacting financial results

Profit margins (9.8%) are lower than last year (21.2%)


PODD * Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Insulet Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Insulet
Historical stock prices
Current Share PriceUS$6,038.64
52 Week HighUS$6,170.25
52 Week LowUS$5,118.00
Beta1.38
1 Month Change0%
3 Month Changen/a
1 Year Change9.41%
3 Year Change4.33%
5 Year Changen/a
Change since IPO-0.29%

Recent News & Updates

Recent updates

Shareholder Returns

PODD *MX Medical EquipmentMX Market
7D0%0%0%
1Y9.4%0%0%

Return vs Industry: PODD * exceeded the MX Medical Equipment industry which returned 1.6% over the past year.

Return vs Market: PODD * underperformed the MX Market which returned 17.6% over the past year.

Price Volatility

Is PODD *'s price volatile compared to industry and market?
PODD * volatility
PODD * Average Weekly Movementn/a
Medical Equipment Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in MX Market0%
10% least volatile stocks in MX Market0%

Stable Share Price: PODD *'s share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine PODD *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20003,900Ashley McEvoywww.insulet.com

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.

Insulet Corporation Fundamentals Summary

How do Insulet's earnings and revenue compare to its market cap?
PODD * fundamental statistics
Market capMex$428.55b
Earnings (TTM)Mex$4.51b
Revenue (TTM)Mex$46.18b
95.1x
P/E Ratio
9.3x
P/S Ratio

Is PODD * overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PODD * income statement (TTM)
RevenueUS$2.52b
Cost of RevenueUS$733.10m
Gross ProfitUS$1.79b
Other ExpensesUS$1.54b
EarningsUS$246.20m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)3.50
Gross Margin70.93%
Net Profit Margin9.76%
Debt/Equity Ratio73.3%

How did PODD * perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/15 01:29
End of Day Share Price 2025/08/18 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Insulet Corporation is covered by 50 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
null nullBaird
Travis SteedBarclays